SRPT - Sarepta Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue154,5845,4211,253
Cost of Revenue7,353101-
Gross Profit147,2315,3201,253
Operating Expenses
Research Development166,707188,272146,394
Selling General and Administrative122,68283,74975,043
Non Recurring28,42728,42728,427
Total Operating Expenses318,869--
Operating Income or Loss-171,638-266,730-220,184
Income from Continuing Operations
Total Other Income/Expenses Net125,000125,000125,000
Earnings Before Interest and Taxes-48,628-267,265-220,030
Interest Expense---
Income Before Tax-48,628-267,265-220,030
Income Tax Expense2,060--
Minority Interest---
Net Income From Continuing Ops-50,688-267,265-220,030
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-50,688-267,265-220,030
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-50,688-267,265-220,030